AVCN.TO
Avicanna Inc
Price:  
0.22 
CAD
Volume:  
318,726.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AVCN.TO EV/EBITDA

-
Upside

As of 2026-01-18, the EV/EBITDA ratio of Avicanna Inc (AVCN.TO) is -15.64. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVCN.TO's latest enterprise value is 25.45 mil CAD. AVCN.TO's TTM EBITDA according to its financial statements is -1.63 mil CAD. Dividing these 2 quantities gives us the above AVCN.TO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples - -
Forward P/E multiples - -
Fair Price - -
Upside - -
0.22 CAD
Stock Price
- CAD
Fair Price

AVCN.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-01-12 -16.37
2026-01-09 -16.37
2026-01-08 -16.00
2026-01-07 -15.64
2026-01-06 -16.00
2026-01-05 -16.37
2026-01-02 -15.64
2025-12-30 -16.00
2025-12-29 -15.28
2025-12-24 -16.37
2025-12-23 -16.37
2025-12-22 -16.37
2025-12-19 -16.00
2025-12-18 -16.37
2025-12-17 -16.37
2025-12-16 -16.37
2025-12-15 -15.64
2025-12-12 -15.64
2025-12-11 -15.64
2025-12-10 -14.92
2025-12-09 -16.00
2025-12-08 -15.64
2025-12-05 -16.37
2025-12-04 -17.09
2025-12-03 -17.09
2025-12-02 -15.64
2025-12-01 -17.45
2025-11-28 -17.09
2025-11-27 -17.81
2025-11-26 -16.00
2025-11-25 -16.73
2025-11-24 -17.09
2025-11-21 -17.09
2025-11-20 -17.81
2025-11-19 -18.54
2025-11-18 -17.45
2025-11-17 -16.00
2025-11-14 -18.18
2025-11-13 -19.26
2025-11-12 -18.54
2025-11-11 -17.81
2025-11-10 -18.54
2025-11-07 -18.18
2025-11-06 -18.18
2025-11-05 -18.18
2025-11-04 -17.45
2025-11-03 -19.26
2025-10-31 -19.26
2025-10-30 -18.54
2025-10-29 -18.90